Michael S. Aberman, SVP Strategy Investor Relation at REGENERON PHARMACEUTICALS INC (REGN), sold 769 shares at $531.51 ($407K) on 2017-06-22, disclosed to the SEC on 2017-06-23.
Open-market sale of $407k REGN by SVP Strategy Investor Relation. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $525.21 | 395 | $207K | 51.0% |
| 2 | $531.51 | 274 | $146K | 35.8% |
| 3 | $538.30 | 100 | $54K | 13.2% |
| Total | $529.16 avg | 769 | $407K | 100% |
| Filing → |
| REGN | SELL | 2015-03-25 | $2.3M | — | Filing → |
| REGN | SELL | 2015-03-19 | $1.6M | — | Filing → |
| REGN | SELL | 2015-02-25 | $1.4M | — | Filing → |